GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796–829.

Article  Google Scholar 

Kramvis A, Chang KM, Dandri M, et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022;19:727–45.

Article  PubMed  PubMed Central  Google Scholar 

Lok AS. Hepatitis B treatment: what we know now and what remains to be researched. Hepatol Commun. 2018;3:8–19.

Google Scholar 

Tout I, Loureiro D, Mansouri A, et al. Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development. J Hepatol. 2020;73:409–22.

Article  CAS  PubMed  Google Scholar 

Yip TC, Wong GL, Chan HL, et al. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. J Hepatol. 2019;70:361–70.

Article  CAS  PubMed  Google Scholar 

Anderson RT, Choi HSJ, Lenz O, et al. Association between seroclearance of hepatitis B surface antigen and long-term clinical outcomes of patients with chronic hepatitis B virus infection: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19:463–72.

Article  CAS  PubMed  Google Scholar 

Hsueh RC, Wu WJ, Lin CL, et al. Impact of PNPLA3 p. I148M and hepatic steatosis on long-term outcomes for hepatocellular carcinoma and HBsAg seroclearance in chronic hepatitis B. J Hepatocell Carcinoma. 2022;9:301–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yip TC, Wong VW, Lai MS, et al. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss. J Hepatol. 2023;78:524–33.

Article  CAS  PubMed  Google Scholar 

Kim GA, Lee HC, Kim MJ, et al. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance. J Hepatol. 2015;62:1092–9.

Article  PubMed  Google Scholar 

Yip TC, Chan HL, Wong VW, et al. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2017;67:902–8.

Article  CAS  PubMed  Google Scholar 

Choi J, Yoo S, Lim YS. Comparison of long-term clinical outcomes between spontaneous and therapy-induced HBsAg seroclearance. Hepatology. 2021;73:2155–66.

Article  CAS  PubMed  Google Scholar 

Yang H, Bae SH, Nam H, et al. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2022;77:632–41.

Article  CAS  PubMed  Google Scholar 

Yip TC, Wong VW, Chan HL, et al. Effects of diabetes and glycemic control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen. Clin Gastroenterol Hepatol. 2018;16:765–73.

Article  CAS  Google Scholar 

Kuang XJ, Jia RR, Huo RR, et al. Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Viral Hepat. 2018;25:1026–37.

Article  CAS  PubMed  Google Scholar 

Yeo YH, Ho HJ, Yang HI, et al. Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis. Gastroenterology. 2019;156:635–46.

Article  CAS  PubMed  Google Scholar 

Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98.

Article  CAS  PubMed  Google Scholar 

Yu MW, Shih WL, Lin CL, et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol. 2008;26:5576–82.

Article  PubMed  Google Scholar 

Yu MW, Lin CL, Liu CJ, et al. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study. Gastroenterology. 2017;153:1006–17.

Article  PubMed  Google Scholar 

Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994;17:71–91.

Article  CAS  PubMed  Google Scholar 

de Wreede LC, Fiocco M, Putter H. mstate: an R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011;38:1–30.

Article  Google Scholar 

Neumann JT, Thao LTP, Callander E, et al. A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data. Lancet Healthy Longev. 2022;3:e89–97.

Article  PubMed  PubMed Central  Google Scholar 

Wu WJ, Lin CL, Liu CJ, et al. Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B. J Med Virol. 2023;95: e29138.

Article  CAS  PubMed  Google Scholar 

Wu CF, Yu MW, Lin CL, et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis. 2008;29:106–12.

Article  CAS  PubMed  Google Scholar 

Chien RN, Liaw YF. Current trend in antiviral therapy for chronic hepatitis B. Viruses. 2022;14:434.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung YC, Lin CL, Liu CJ, et al. Development of risk scoring system for stratifying population for hepatocellular carcinoma screening. Hepatology. 2015;61:1934–44.

Article  CAS  PubMed  Google Scholar 

Wang YH, Chuang YH, Wu CF, et al. Smoking and hepatitis B virus-related hepatocellular carcinoma risk: the mediating roles of viral load and alanine aminotransferase. Hepatology. 2019;69:1412–25.

Article  CAS  PubMed  Google Scholar 

Kim K, Choi S, Park SM. Association of high body mass index and hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a Korean population-based cohort study. JAMA Oncol. 2018;4:737–9.

Article  PubMed  PubMed Central  Google Scholar 

Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.

Article  CAS  PubMed  Google Scholar 

Yu MW, Lin CL, Liu CJ, et al. Metabolic-associated fatty liver disease, hepatitis B surface antigen seroclearance, and long-term risk of hepatocellular carcinoma in chronic hepatitis B. Cancers (Basel). 2022;14:6012.

Article  CAS  PubMed  Google Scholar 

Wong YJ, Nguyen VH, Yang HI, et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023;29:705–20.

Article  PubMed  PubMed Central  Google Scholar